Ginger ale has long been considered a non-medicinal option for soothing upset stomachs. Didier Merlin, MD, and colleagues from the Atlanta VA medical Center and Institute for Biomedical Sciences at Georgia State University, have taken this concept a step further, exploring the use of edible ginger-derived nanoparticles (GDNPs) to treat inflammatory bowel disease.
MD Magazine spoke with world-renowned soccer star, Brandi Chastain, who recently partnered with AbbVie on a new advocacy campaign, My IBD Game Plan, in the wake of her son’s Crohn’s disease diagnosis. Millie Long, MD, MPH, shared the clinical landscape and management methods for the condition.
Patients afflicted with ulcerative colitis (UC) that practiced hatha yoga – a practice of physical yoga postures – for a 12-week period noticed a significant decline in their disease activity.
Tonsillectomies have typically been considered to be one of the surgical procedures younger patients often irrationally fear.
Could a special type of intestinal cell be at the root of inflammatory bowel disease? Researchers from Rutgers University Newark (RU N) believed so, and wanted to determine how to alter the cells’ behavior to eliminate the disease.
The pharmaceutical company Shire won a patent trial concerning mesalamine (Lialda), an ulcerative colitis drug, according to a company press release.
Previously associated primarily with assessing blood alcohol level, breath tests can now aid in accurately distinguishing irritable bowel syndrome (IBS).
Anorexia nervosa, chronic fatigue syndrome, and irritable bowel syndrome (IBS) might not be the typical threesome, but these three conditions do share a common origin.
The field of gastroenterology is as wide as the the amount of the body that it covers. Because of this there are certain challenges doctors face whether they treat the entire gastrointestinal system or just specific parts.
Despite green tea’s many health benefits, combining it with dietary iron does not produce any benefits for inflammatory bowel disease (IBD) patients.
Migraine and tension headaches potentially share genetic links with irritable bowel syndrome (IBS).
Patients suffering from irritable bowel syndrome (IBS) can reduce their symptoms with the substance ebastine found in histamines used to treat hay fever.
Patients with irritable bowel disease can have enough issues to deal with in their daily lives. Add a condition like c-diff can make the treatment that much more complicated.
The US Food and Drug Administration recently approved the Fenix Continence Restoration System for the treatment of fecal incontinence for patients who have tried and failed other medical and surgical options.
Francisco Sylvester, MD, UNC School of medicine emphasized the importance of applying study findings to early interventions in treatment.
Study results show that patients with ulcerative colitis who undergo hematopoietic stem cell transplantation (HSCT) had higher rates of opportunistic infections and inpatient mortality compared to transplant patients who did not have UC.
Russell Cohen, MD, director of the Inflammatory Bowel Diseases Center at The University of Chicago Medicine continued to discuss the relevance of healthcare economics specific to IBD at the 2015 Advances in Inflammatory Bowel Diseases.
Treatment for irritable bowel syndrome (IBS) is significantly more expensive when treated in secondary care settings than it is when treated in primary care settings -- without a corresponding increase in treatment effectiveness.
Changes in gut bacterial growth rates may be linked to onset of diseases, such as type 2 diabetes or irritable bowel syndrome, for example, according to research published in the journal Science.
A recent review article provided updated information on classification systems, preventive techniques, pathophysiological mechanisms, and treatment options for postoperative ileus.
Adults who experienced physical or sexual abuse in their lifetime have a higher risk of developing ulcerative colitis (UC).
The internet can be an endless source of information for patients looking to learn more about their conditions and possible treatments and surgical options. Whether those sources provide the help needed is another issue for healthcare professionals to tackle.
Daily vitamin D has been found to potentially aid in Crohn's disease (CD) treatment, according to research published in the journal United European Gastroenterology.
The US Food and Drug Association (FDA) granted approval for eluxadoline (Viberzi) and rifaximin (Xifaxan), to treat irritable bowel syndrome with diarrhea (IBS-D) in adult men and women.
Patients with long-standing ulcerative colitis have shown signs of being more at risk for developing cancer. Research has looked at why that is the case and what can be done to prevent the cancer from progressing.
